在儿童喘恶化期间,LPS结合蛋白和激活特征被上调
Anya C Jones1,2, Jonatan Leffler1, Ingrid A Laing1,3
1Wal-yan Respiratory Research Centre, Telethon Kids Institute, University of Western Australia, Perth, WA, Australia.
Respiratory research
|July 12, 2023
概括
儿童喘恶化涉及全身免疫系统的变化. 在恶化期间,外围血液单核细胞 (PBMC) 中的基因网络揭示了免疫原始化和潜在的气道迁移预编程.
科学领域:
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
- 儿科医学 儿科医学
背景情况:
- 儿童喘恶化与病毒感染和亚托皮有关,导致系统性免疫激活和呼吸道炎症.
- 控制这种免疫激活和细胞迁移到呼吸道的特定基因网络尚未完全理解.
- 了解这些网络对于开发针对儿童喘的向治疗至关重要.
研究的目的:
- 在急性恶化和康复期间,识别和分析在性喘儿童的外周血液单核细胞 (PBMC) 中的基因协同表达网络.
- 推断这些网络的驱动因素,并了解它们在系统性免疫激活和呼吸道炎症中的作用.
- 验证在独立的喘儿童队伍中发现的结果.
主要方法:
- 从19名在恶化和康复期间的非热性喘儿童中对结合PBMC的细胞和分子概况.
- 系统层面的分析,以识别共同表达网络并推断网络驱动器.
- 使用来自喘儿童的独立样本进行验证.
主要成果:
- 在恶化期间,PBMC免疫细胞丰度和复杂,相互连接的基因网络上调的显著变化.
- 确定了与先天性免疫原始化,炎症和呼吸道重塑相关的激活特征,包括对LPS,葡萄皮质激素和TGFB1.1的反应.
- 确认了血中LPS结合蛋白的升高调节,并确定了在循环PBMC中涉及喘病变的多个基因网络.
结论:
- 喘儿童的系统性免疫细胞表现出预先编程的功能,包括保护性和致病性,在恶化期间迁移到呼吸道之前.
- 对脂聚糖 (LPS) 的增强敏感性可能会影响喘恶化的严重程度,可能是由于环境中的LPS暴露.
- 这些发现突显了儿科喘恶化中免疫反应的全身性质,并表明了潜在的治疗点.
相关概念视频
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Antiasthma Drugs: Leukotriene Modifiers
368
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
368
Asthma: Pathogenesis and Management
450
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
450
Asthma-I: Introduction
2.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K


